Here’s whether Viking Therapeutics, Inc (VKTX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.40% over 10 days); RSI 39 — healthy momentum range; 3-month momentum positive (+6.2%). Concerns: declining volume on rally — weak conviction (0.69x 30d avg). Currently 19.4% off its 52-week high. Score: +5/7.
VKTX is in a confirmed uptrend, trading above both its 50-day ($33.69) and 200-day ($33.79) moving averages. An RSI of 38.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +3.9% compares to +16.5% for SPY (trailed the market by 12.6%).
$10,000 invested 1 year ago→ $10,385 today
vs. S&P 500 (SPY) — same period trailed market by 12.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($33.79)
✓Above 50-day MA ($33.69)
✓RSI(14) neutral zone (30–70) — currently 38.9
✓Positive return (+3.9%)
!Within 10% of period high (−19.4%)
Period Range $34.79
$22.96$43.15
RSI (14) 38.9
0 · OversoldOverbought · 100
Key Metrics
Price$34.79
Period Return+3.9%
Period High$43.15
Period Low$22.96
Drawdown−19.4%
MA-50$33.69
MA-200$33.79
RSI (14)38.9
Avg Volume (30d)2.6M
vs. SPYtrailed by 12.6%
Return Rank#491 of 999
Trend Signals
Price is above the 200-day moving average ($33.79)